These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 8397930)

  • 21. Evolution and clinical significance of the T cell proliferative and cytokine response directed against the fibronectin binding antigen 85 complex of bacillus Calmette-Guerin during intravesical treatment of superficial bladder cancer.
    Zlotta AR; Drowart A; Van Vooren JP; de Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
    J Urol; 1997 Feb; 157(2):492-8. PubMed ID: 8996341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotypic characterization of the bladder mucosa infiltrating lymphocytes after intravesical BCG treatment for superficial bladder carcinoma.
    Boccafoschi C; Montefiore F; Pavesi M; Pastormerlo M; Annoscia S; Lozzi C; Betta PG
    Eur Urol; 1992; 21(4):304-8. PubMed ID: 1459153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment.
    Hori S; Miyake M; Tatsumi Y; Morizawa Y; Nakai Y; Onishi S; Onishi K; Iida K; Gotoh D; Itami Y; Tanaka N; Fujimoto K
    Oncol Rep; 2019 Mar; 41(3):1863-1874. PubMed ID: 30628699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).
    Günther JH; Frambach M; Deinert I; Brandau S; Jocham D; Böhle A
    J Urol; 1999 May; 161(5):1702-6. PubMed ID: 10210443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3/Nrf2 pathway.
    Mao MH; Huang HB; Zhang XL; Li K; Liu YL; Wang P
    Biomed Pharmacother; 2018 Nov; 107():1093-1103. PubMed ID: 30257321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravesical BCG administration in the guinea pig. II. Immunohistochemical characterization of cellular infiltrate after one or two cycles of intravesical BCG.
    de Jong WH; De Boer EC; Van Der Meijden AP; Steerenberg PA; Debruyne FM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(3):159-67. PubMed ID: 1685277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of tumor necrosis factor by intravesical administration of bacillus Calmette Guérin in patients with superficial bladder cancer.
    Kim CI; Shin JS; Kim HI; Lee JM; Kim SJ
    Yonsei Med J; 1993 Dec; 34(4):356-64. PubMed ID: 8128741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced antitumor effect of Bacillus Calmette-Guérin in combination with fibrinogen on urinary bladder tumor.
    Mizutani Y; Nio Y; Fukumoto M; Yoshida O
    J Urol; 1994 May; 151(5):1420-6. PubMed ID: 8158799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2.
    Takahashi T; Kushiro A; Nomoto K; Uchida K; Morotomi M; Yokokura T; Akaza H
    J Urol; 2001 Dec; 166(6):2506-11. PubMed ID: 11696819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic versus localized Bacillus Calmette Guérin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
    Atallah A; Grossman A; Nauman RW; Paré JF; Khan A; Siemens DR; Cotechini T; Graham CH
    Int J Cancer; 2024 Jul; 155(2):352-364. PubMed ID: 38483404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells.
    Luo Y; Yamada H; Evanoff DP; Chen X
    Clin Exp Immunol; 2006 Oct; 146(1):181-8. PubMed ID: 16968412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term immunobiological effects of intravesical bacillus Calmette-Guérin against bladder carcinoma recurrences.
    Böhle A; Busemann E; Gerdes J; Ulmer AJ; Flad HD; Jocham D
    Dev Biol Stand; 1992; 77():199-209. PubMed ID: 1426663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model.
    Yoshino T; Miyazaki J; Kojima T; Kandori S; Shiga M; Kawahara T; Kimura T; Naka T; Kiyohara H; Watanabe M; Yamasaki S; Akaza H; Yano I; Nishiyama H
    PLoS One; 2019; 14(1):e0209196. PubMed ID: 30608942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of tumour necrosis factor-alpha (TNF-alpha) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Guérin.
    Shin JS; Park JH; Kim JD; Lee JM; Kim SJ
    Clin Exp Immunol; 1995 Apr; 100(1):26-31. PubMed ID: 7697918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fate of bacillus Calmette-Guerin after intravesical instillation.
    Durek C; Richter E; Basteck A; Rüsch-Gerdes S; Gerdes J; Jocham D; Böhle A
    J Urol; 2001 May; 165(5):1765-8. PubMed ID: 11342972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F; Schuster F
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma.
    Böhle A; Rüsch-Gerdes S; Ulmer AJ; Braasch H; Jocham D
    J Urol; 1996 Jun; 155(6):1892-6. PubMed ID: 8618281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental and clinical study of intravesical BCG therapy. The role in the prevention of recurrence of superficial bladder tumor].
    Hirano A
    Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1052-61. PubMed ID: 1507722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.